Prevalence and pattern of renal bone disease in end stage renal disease patients in Ile-Ife, Nigeria;Prévalence et les tendances de la maladie des os rénale chez les patients avec l'insuffisance rénale terminale en Ile-Ife, Nigéria

West African Journal of Medicine

Volumn 29, Issue 2, 2010, Pages 75-80

  Sanusi, A A ^a   Arogundade, F A ^a   Oladigbo, M ^a   Ogini, L M ^a   Akinsola, A ^a  

^a OBAFEMI AWOLOWO UNIVERSITY TEACHING HOSPITALS COMPLEX   (Nigeria)

Author keywords

End state renal disease; Prevalence; Renal bone disease

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DISEASE; BONE TURNOVER; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DIALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERPARATHYROIDISM; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; NIGERIA; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREVALENCE; RENAL OSTEODYSTROPHY; SYMPTOM; UREMIA; ADOLESCENT; AGE DISTRIBUTION; AGED; BLOOD; CHRONIC KIDNEY FAILURE; MIDDLE AGED; PAIN; RADIOGRAPHY; RENAL REPLACEMENT THERAPY; SEX RATIO;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CALCIUM; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NIGERIA; PAIN; PARATHYROID HORMONE; PREVALENCE; RENAL DIALYSIS; RENAL OSTEODYSTROPHY; SEX DISTRIBUTION; YOUNG ADULT;

EID: 78049404277     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Reiss E, Canterbury JM, Egdahl RH. Measurement of serum parathyroid hormone in renal insufficiency. Trans Assoc Am Phys. 1968; 81: 104-115.
2. Arnaud CD. Hyperparathyroidism and renal failure. Kidney Int 1973; 4: 89-95.
3. Smith A, Faugere M, Abreo K. Aluminium associated bone disease in renal failure. A study on prevalence, histopathology, aetiology and diagnosis in 197 patients. Am J Nephrol. 1986; 6: 275-283.
4. Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EB, Freemont TJ, et al. Correlation of bone histology with parathyroid hormone, vitamin D3 and radiology in end stage renal disease. Kidney Int. 1993; 44: 1071-7.
5. Moe S, Drueke T, Cunningham I, Cannata-Andía JB, Elder GJ, Fukagawa M, et al. Definition, evaluation and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Gllobal Outcomes (KDIGO). Kidney Int 2006; 69: 1945-53.
6. Akinsola W, Odesanmi WO, Ogunniyi JO, Ladipo GO. Diseases causing chronic renal failure in Nigerians: a prospective study of 100 cases. Afr J Med Med Sci. 1989; 18: 131-7.
7. Kadiri S, Arije A. Temporal variations and meterological factors in hospital admissions of chronic renal failure in south West Nigeria. West Afr J Med 1999; 18: 49-51.
8. Akinsola A, Akinkugbe OO. Chronic renal failure in the tropics, clinical features and strategies in management. Postgraduate Doctor. 1989; 12: 1118-1130.
9. Onyemekeihia R, Renal osteodystrophy in Benin. A dissertation submitted to the National Postgraduate Medical College of Nigeria, Faculty of Internal Medicine November 2004.
10. Boner G, Olah AJ, Weiss A, Seelenfreund MZ, Rosenfeld JB. Renal osteodystrophy in end-stage renal failure patients in Israel. Isr J Med Sci 1983;19: 608-13.
11. Second annual report of the Egyptian Society of Nephrology, 1997: http://http://163.121.19.91/esnnew/data1997.htm
12. Jaros A, Zadrazil J, Konecny K, Kosatíková Z, Zahálková J, Vrublovský P, et al. Single photon bone densitometry in hemodialysis patients. Acta Univ Palacki Olomuc Fac Med 1999; 142: 135-8.
13. Llach F. Hyperphosphataemia in end stage renal disease patients: pathophysiological consequences. Kidney Int. 1999; 56: S31-S37.
14. Changsirikulchai S, Domrongkitchaiporn S, Sirikulchayanonta V, Ongphiphadhanakul B, Kunkitti N, Stitchantrakul W, et al. Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation. J Med Assoc Thai 2000; 83: 1223-32.
15. Jorgetti V, Lopez BD, Caorsi H, Ferreira A, Palma A, Menendez P, et al. Different patterns of renal osteodystrophy in Iberoamerica. Am J Med Sci 2000; 320: 76-80.
16. Malluche HH, Langub MC, Mounier-Faugere M. The role of bone biopsy in clinical practice and research. Kidney Int. 1999; 56: S20-S25.
17. Adams JE. Renal bone disease: radiological investigation. Kidney Int. 1999: 56(suppl 73): S38-S41.
18. Adelekun A, Akinsola A. Hypertension induced chronic renal failure: Clinical features, management and prognosis. West Afr J Med 1998; 17: 104-8.
19. Ojogwu LI. Pathologic basis of end stage renal disease in Nigeria: Experience from Benin. West Afr J Med 1990; 9: 193-6.
20. Sanusi AA, Akinsola A, Ajayi AA. Creatinine clearance estimation from serum creatinine values: evaluation and comparison of five prediction formulae in Nigerian patients. Afr J Med Med Sci. 2000; 29: 7-11.
21. Endres DB, Villanueva R, Sharp CF Jr, Singer FR. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: Performance in the differential diagnosis of hypercalcemia and hypoparathyroidism. Clin Chem 1991; 37: 162-8.
22. Michelangeli, VP, Heyma, P, Colman, PG, Ebeling PR. Evaluation of a new, rapid and automated Immunochemiluminometric assay for the measurement of serum intact parathyroid hormone. Ann Clin Blochem 1997; 34: 97-103.
23. Statopolsky E, Bricker NS. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic kidney disease. Kidney Int. 1973; 4: 141-5.
24. Hsu CH. Are we mismanaging calcium and phosphate metabolism in renal failure? Am J Kidney Dis 1997; 29: 641-9.
25. Combe C, Aparicio M Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney Int. 1994; 46: 1381-6.
26. Jara A, Chacón C, Felsenfeld AJ. How dietary phosphate, renal failure and calcitriol administration affect the serum calcium-phosphate relationship in the rat. Nephrol Dial Transplant. 2002; 17: 765-71.
27. Malluche, HH, Monier-Faugere, MC. Risk of adynamic bone disease in dialyzed patients. Kidney Int Suppl 1992; 38: S62-S67.
28. Moe SM, Sprague SM. Mineral Bone Disorders in Chronic Kidney Disease. In Brenner B Eds. The Kidney W. B Saunders 2008; Chapter 52: 1784-1813.
29. Krpan D, Lajtman Z, Erceg I, Ivcosic A. Renal Osteodystrophy Based on Bone Histomorphometry: 20 Years of Experience. Dialysis & Transplantation 2004; 33: 476-482.
30. Malluche HH, Faugere MC, Fanti P, Price PA: Plasma levels of bone Glaprotein reflect bone formation in patients on chronic maintenance dialysis. Kidney Int 1984; 26: 869-874.
31. Baskin E, Besbas N, Saatci U, Hasçelik G, Topalo{eth}lu R, Ozen S, et al. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialysed children. Turk J Paediatrics 2004; 46: 28-31.
32. Weinstein, RS, Underwood, JL, Hutson, MS, DeLuca, HF. Bone histoplasmorphometry in vitamin Ddeficient rats infused with calcium and phosphorus. Am J Physiol 1984; 246: E499-E505.
33. Meema HE, Rabinovich S, Meema S, Lloyd GJ, Oreopoulos DG. Improved radiological diagnosis of azotemic osteodystrophy. Radiology 1972; 102: 1-10.
34. Odenigbo UC, Ijoma CK, Ulasi I, Udeh AC, Ibeh CC. The prevalence of radiological markers of renal osteodystrophy in patients with chronic renal failure in Enugu. Niger J Clin Pract. 2006; 9: 147-52.
35. Lye WC; Lee EJ. Renal bone disease in patients on haemodialysis: biochemical and radiological assessment. Ann Acad Med Singapore 1992; 2: 760-4.